Eurofins · 17 hours ago
Cell Core Analyst
Rensselaer, NY, USA
Full-time
Onsite
New Grad, Entry Level
$21.50/hr - $22.50/hrEurofins is an international life sciences company providing a unique range of analytical testing services across multiple industries. The Cell Core Analyst will maintain mammalian cell lines, support clinical cell line activities, and ensure compliance with established SOPs while collaborating with internal teams and external partners.
BiotechnologyHealthcarePharmaceuticalLife ScienceGeneticsHealth Care
No H1B
Responsibilities
Maintain both suspension and adherent mammalian cell lines
Support thawing, expansion, and banking of clinical cell lines
Prepare media and reagents needed for routine cell culture work
Follow established SOPs and maintain compliance in all activities
Complete laboratory documentation and review logbook entries
Calibrate or verify calibration of instruments before use
Participate in required training and skill‑building activities
Maintain lab supplies and support day‑to‑day lab operations
Communicate and collaborate with internal teams and external partners
Qualification
Required
Bachelor's degree in biochemistry or a related scientific field
Hands-on experience working with mammalian cell lines
Experience operating in a GMP-regulated environment
Strong pipetting technique and comfort with routine lab workflows
Authorization to work in the United States indefinitely without restriction or sponsorship
Positive, adaptable, team-oriented mindset with strong attention to detail
Learns new techniques quickly and follows procedures accurately
Clear written and verbal communication skills
Comfortable with a moderately physical role involving extended standing
Organized, computer-proficient, and able to work reliably in a structured environment
Company
Eurofins
Eurofins provides testing and support services to the pharmaceutical, food, environmental, and consumer products industries.
Founded in 1987
10001+ employees
Funding
Current Stage
Public CompanyTotal Funding
$1.05B2025-06-26Post Ipo Debt· $584.64M
2025-03-27Post Ipo Debt· $432.03M
2021-10-22Grant· $30M
Leadership Team
C
Cara Ahern
Documentation Specialist
Yves-Loic Martin
Board Member
Recent News
2025-12-16
Business Wire
2025-12-08
Company data provided by crunchbase